Bukwang Pharm (003000) — Capital Reinvestment Ratio
Latest as of June 2025:
0.28x
Bukwang Pharm (003000) has a Capital Reinvestment Ratio of 0.28x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩10.03 Billion) in capital expenditures (₩2.80 Billion). See how much free cash does Bukwang Pharm generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.28x
Capex / Operating Cash Flow
Operating Cash Flow
₩10.03 Billion
KRW
Capital Expenditures
₩2.80 Billion
KRW
Data as of
Jun 2025
Most recent filing
Bukwang Pharm Capital Reinvestment Ratio (2007–2024)
This chart tracks Bukwang Pharm's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Bukwang Pharm (2007–2024)
Year-by-year Capital Reinvestment Ratio for Bukwang Pharm from 2007 to 2024. For live market cap and broader valuation context, see Bukwang Pharm stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | ₩34.36 Billion | ₩2.61 Billion | ▼ -74.9% |
| 2022 | 0.30x | ₩16.46 Billion | ₩4.99 Billion | ▲ +924.3% |
| 2021 | 0.03x | ₩26.52 Billion | ₩785.05 Million | ▼ -98.9% |
| 2020 | 2.65x | ₩723.17 Million | ₩1.92 Billion | ▲ +387.4% |
| 2018 | 0.54x | ₩6.82 Billion | ₩3.71 Billion | ▲ +3.8% |
| 2017 | 0.52x | ₩8.56 Billion | ₩4.49 Billion | ▲ +17.8% |
| 2015 | 0.44x | ₩10.30 Billion | ₩4.58 Billion | ▲ +317.6% |
| 2014 | 0.11x | ₩27.86 Billion | ₩2.97 Billion | ▲ +3.8% |
| 2013 | 0.10x | ₩36.52 Billion | ₩3.74 Billion | ▼ -86.2% |
| 2007 | 0.74x | ₩27.87 Billion | ₩20.69 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow